D-Lina M 2.5 mg+500 mg (Tablet)
Unit Price: ৳ 11.50 (3 x 10: ৳ 345.00)
Strip Price: ৳ 115.00
Medicine Details
Category | Details |
---|---|
Generic | Linagliptin metformin hydrochloride |
Company | Desh pharmaceuticals ltd |
Also available as |
Indications
- Adjunct to diet and exercise
- Improves glycemic control
- Type 2 diabetes mellitus
Pharmacology
- Inhibitor of DPP-4 enzyme
- Increases active incretin hormones
- Stimulates insulin release
- Decreases glucagon secretion
- Oral antihyperglycemic drug
- Lowers plasma glucose
- Decreases hepatic glucose production
- Improves insulin sensitivity
Dosage & Administration
- Individualized dosage based on effectiveness and tolerability
- Maximum recommended dose of 2.5 mg Linagliptin and 1000 mg Metformin Hydrochloride twice daily with meals
- Dose escalation should be gradual
- Immediate release and extended release tablet options
- Starting dose recommendations for different patient groups
Interaction
- Cationic drugs interaction
- Carbonic Anhydrase Inhibitors interaction
- Inducers of P-glycoprotein and CYP3A4 Enzymes interaction
- Drugs affecting glycemic control interaction
Contraindications
- Contraindicated in renal impairment
- Contraindicated in acute or chronic metabolic acidosis
- Contraindicated in hypersensitivity to Linagliptin or Metformin Hydrochloride
Side Effects
- Common side effects: nasopharyngitis and diarrhea
- Increased risk of hypoglycemia
Pregnancy & Lactation
- Use during pregnancy only if clearly needed
- Caution during lactation
Precautions & Warnings
- Discontinue in case of lactic acidosis
- Discontinue in case of suspected pancreatitis
- Temporary discontinuation for certain medical procedures
- Monitoring of Vitamin B12 levels
- Symptoms of lactic acidosis and pancreatitis
- Instructions for alcohol, other medicines, counseling, travel, and emergencies
- Caution for hypoglycemia
Overdose Effects
- Supportive measures for overdose
- Low likelihood of Linagliptin removal by dialysis
- Metformin Hydrochloride is dialyzable
- No dose-related clinical adverse reactions for Linagliptin overdose
- Hypoglycemia reported in Metformin overdose cases
- Lactic acidosis reported in Metformin overdose cases
Therapeutic Class
- Combination Oral hypoglycemic preparations
Storage Conditions
- Cool and dry storage below 30°C
- Protection from light and moisture
- Keep out of the reach of children
Related Brands
- Linadus M XR 5 mg+1000 mg (Tablet (Extended Release)) - opsonin-pharma-ltd
- LG-M 2.5 mg+500 mg (Tablet) - silco-pharmaceutical-ltd
- Ligazid MX 5 mg+1000 mg (Tablet (Extended Release)) - eskayef-pharmaceuticals-ltd
- Renolina M 2.5 mg+850 mg (Tablet) - dbl-pharmaceuticals-ltd
- Renolina M 2.5 mg+500 mg (Tablet) - dbl-pharmaceuticals-ltd